References
- O’Donnell DE, Aaron SD, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J. 2007;14(Suppl B):5B–32B. DOI:10.1155/2007/926421
- Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. DOI:10.7189/jogh.05-020415
- Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61(6):1–51.
- O’Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive Research pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008; 15(15 Suppl A):1A–8A. DOI:10.1155/2008/641965
- Keene JD, Jacobson S, Kechris K, et al. Biomarkers predictive of exacerbations in the SPIROMICS and COPDGene cohorts. Am J Respir Crit Care Med. 2017;195(4):473–481. DOI:10.1164/rccm.201607-1330OC
- Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959–967. DOI:10.1164/ajrccm.154.4.8887592
- Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459–467. DOI:10.1378/chest.124.2.459
- Donaldson GC, Wedzicha JA. COPD exacerbations .1: Epidemiology. Thorax. 2006;61(2):164–168. DOI:10.1136/thx.2005.041806
- Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. DOI:10.1164/rccm.201701-0218PP
- Titova E, Steinshamn S, Indredavik B, et al. Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study. Respir Res. 2015;16(1):8. DOI:10.1186/s12931-015-0170-1
- Lawlor M, Kealy S, Agnew M, et al. Early discharge care with ongoing follow-up support may reduce hospital readmissions in COPD. Int J Chron Obstruct Pulmon Dis. 2009;4:55–60.
- Fan VS, Niewoehner DE, Lew R. A Comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations. Ann Intern Med. 2012;157(7):530. DOI:10.7326/0003-4819-157-7-201210020-00019
- Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689–698. DOI:10.1056/NEJMoa1104623
- Martinez FJ, Calverley P, Goehring U-M, et al. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. Lancet. 2015;385(9971):857–866. DOI:10.1016/S0140-6736(14)62410-7
- Zheng J-P, Wen F-Q, Bai C-X, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014;2(3):187–194. DOI:10.1016/S2213-2600(13)70286-8
- Leigh R, Pizzichini MMM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J. 2006;27(5):964–971. DOI:10.1183/09031936.06.00072105
- Nair P. Update on clinical inflammometry for the management of airway diseases. Can Respir J. 2013;20(2):117–120. DOI:10.1155/2013/602936
- Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J. 2007;29(5):906–913. DOI:10.1183/09031936.00146306
- Pizzichini MMM, Popov TA, Efthimiadis AE, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996;154(4):866–869. DOI:10.1164/ajrccm.154.4.8887576
- McDonald VM, Higgins I, Wood LG, et al. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax. 2013;68(7):691–694. DOI:10.1136/thoraxjnl-2012-202646
- Wang Z, Locantore N, Haldar K, et al. Inflammatory endotype associated airway microbiome in COPD clinical stability and exacerbations – a multi-cohort longitudinal analysis. Am J Respir Crit Care Med. 2020. DOI:10.1164/rccm.202009-3448OC.
- McDonald VM, Clark VL, Cordova-Rivera L, et al. Targeting treatable traits in severe asthma: a randomised controlled trial. Eur Respir J. 2020;55(3):1901509. DOI:10.1183/13993003.01509-2019